United States · FDA National Drug Code directory
CARBAMAZEPINE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68788-7210_fc6363d3-830f-49b8-8aea-e34f47ead0d1
- Product NDC
- 68788-7210
- Form
- TABLET
- Composition / generic term
- CARBAMAZEPINE
- Labeler
- Preferred Pharmaceuticals Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20180806
- Source listing expiry
- 20271231
Source-listed ingredients
- CARBAMAZEPINE — 200 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (68788-7210-1) · 68788-7210-1
- 20 TABLET in 1 BOTTLE (68788-7210-2) · 68788-7210-2
- 30 TABLET in 1 BOTTLE (68788-7210-3) · 68788-7210-3
- 60 TABLET in 1 BOTTLE (68788-7210-6) · 68788-7210-6
- 28 TABLET in 1 BOTTLE (68788-7210-8) · 68788-7210-8
- 90 TABLET in 1 BOTTLE (68788-7210-9) · 68788-7210-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →